{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:49:44Z","timestamp":1774262984543,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.prro.2016.06.010","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T05:30:46Z","timestamp":1466746246000},"page":"e43-e49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1\/2 trial"],"prefix":"10.1016","volume":"7","author":[{"given":"D. Nathan","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Straka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Chinsoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Raben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian Jin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pistenmaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2016.06.010_bb0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/sonc.2002.32902","article-title":"Prostate-specific antigen in prostate cancer: A case study in the development of a tumor marker to monitor recurrence and assess response","volume":"29","author":"Small","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/03008880510030941","article-title":"Prognostic value of serum markers for prostate cancer","author":"Stenman","year":"2005","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.prro.2016.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-5347(17)32422-9","article-title":"The clinical usefulness of prostate specific antigen: Update 1994","volume":"152","author":"Partin","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2016.06.010_bb0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-5347(05)67698-7","article-title":"Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer","volume":"163","author":"Critz","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2016.06.010_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fonc.2014.00008","article-title":"Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer","volume":"4","author":"Vu","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2490-13-49","article-title":"A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy","volume":"13","author":"Bolzicco","year":"2013","journal-title":"BMC Urol"},{"key":"10.1016\/j.prro.2016.06.010_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2013.08.030","article-title":"Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials","volume":"109","author":"King","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1748-717X-8-58","article-title":"Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: The Georgetown University experience","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0045","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1111\/j.1743-7563.2012.01589.x","article-title":"Stereotactic body radiotherapy for prostate cancer: A preliminary report","volume":"10","author":"Lee","year":"2014","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0050","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1002\/cncr.26699","article-title":"Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial","volume":"118","author":"McBride","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2016.06.010_bb0055","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase ii clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2016.06.010_bb0060","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2010.31.4377","article-title":"Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer","volume":"29","author":"Boike","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2014.03.012","article-title":"Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2016.06.010_bb0070","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.urology.2009.01.043","article-title":"Prostate-specific antigen bounce after prostate brachytherapy: Review of a confusing phenomenon","volume":"74","author":"Caloglu","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.prro.2016.06.010_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urology.2005.02.026","article-title":"Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?","volume":"66","author":"Rosser","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.prro.2016.06.010_bb0080","first-page":"1","article-title":"Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer","author":"Kole","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0360-3016(02)04470-X","article-title":"Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications","volume":"56","author":"Stock","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2016.06.010_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brachy.2006.02.003","article-title":"PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup","volume":"5","author":"Toledano","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2016.06.010_bb0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0360-3016(02)02948-6","article-title":"Prostate-specific antigen spikes after permanent prostate brachytherapy","volume":"54","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2016.06.010_bb0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0360-3016(01)01557-7","article-title":"Patterns and fate of psa bouncing following 3d-crt","volume":"50","author":"Hanlon","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2016.06.010_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1538-4721(03)00130-2","article-title":"Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy","volume":"2","author":"Merrick","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2016.06.010_bb0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-717X-9-42","article-title":"Hypofractionated SBRT versus conventionally fractionated ebrt for prostate cancer: Comparison of PSA slope and nadir","volume":"9","author":"Anwar","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2016.06.010_bb0115","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2006.10.1949","article-title":"Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline","volume":"25","author":"Loblaw","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850016301084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850016301084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:19:32Z","timestamp":1761819572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850016301084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1879850016301084"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2016.06.010","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1\/2 trial","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2016.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9<thinsp>2016 American Society for Radiation Oncology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}